Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients.

Deuster E, Mayr D, Hester A, Kolben T, Zeder-Göß C, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B.

Int J Mol Sci. 2019 Jun 12;20(12). pii: E2862. doi: 10.3390/ijms20122862.

2.

A randomized trial comparing limited-excision conisation to Large Loop Excision of the Transformation Zone (LLETZ) in cervical dysplasia patients.

Kolben TM, Etzel LT, Bergauer F, Hagemann I, Hillemanns P, Repper M, Kaufmann AM, Sotlar K, Kolben T, Helms HJ, Gallwas J, Mahner S, Dannecker C.

J Gynecol Oncol. 2019 May;30(3):e42. doi: 10.3802/jgo.2019.30.e42.

3.

Involvement of ILR4α and TLR4 in miscarriages.

Kolben TM, Rogatsch E, Hester A, Kuhn C, Schmoeckel E, Czogalla B, Mahner S, Jeschke U, Kolben T.

J Reprod Immunol. 2019 Feb;131:36-43. doi: 10.1016/j.jri.2018.12.001. Epub 2019 Jan 8.

PMID:
30639993
4.

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients.

Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F.

Int J Mol Sci. 2018 Dec 29;20(1). pii: E112. doi: 10.3390/ijms20010112.

5.

The role of EP3-receptor expression in cervical dysplasia.

Hester A, Ritzer M, Kuhn C, Schmoeckel E, Mayr D, Kolben T, Dannecker C, Mahner S, Jeschke U, Kolben TM.

J Cancer Res Clin Oncol. 2019 Feb;145(2):313-319. doi: 10.1007/s00432-018-2785-3. Epub 2018 Nov 7.

PMID:
30402741
6.

Delayed interval delivery in multiple gestations: the Munich experience.

Kolben T, Fischer D, Ruehl I, Franz M, Hester A, Kolben TM, Deppe C, Delius M, Friese K, Mahner S, Hasbargen U, Hübener C.

Arch Gynecol Obstet. 2019 Feb;299(2):339-344. doi: 10.1007/s00404-018-4959-2. Epub 2018 Nov 1.

PMID:
30386991
7.

Prognostic impact of residual disease in simultaneous additional excision specimens after one-step breast conserving therapy with negative final margin status in primary breast cancer.

Kahlert S, Kolben TM, Schmoeckel E, Czogalla B, Hester A, Degenhardt T, Kempf C, Mahner S, Harbeck N, Kolben T.

Eur J Surg Oncol. 2018 Sep;44(9):1318-1323. doi: 10.1016/j.ejso.2018.06.014. Epub 2018 Jun 23.

PMID:
30041974
8.

PPARγ Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas.

Kolben TM, Rogatsch E, Vattai A, Hester A, Kuhn C, Schmoeckel E, Mahner S, Jeschke U, Kolben T.

Int J Mol Sci. 2018 Jun 26;19(7). pii: E1872. doi: 10.3390/ijms19071872.

9.

Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients.

Burgmann M, Hermelink K, Farr A, van Meegen F, Heiduschk A, Engel J, Kolben T, Degenhardt T, Ditsch N, Mahner S, Harbeck N, Würstlein R.

Breast Care (Basel). 2018 Apr;13(2):126-130. doi: 10.1159/000481340. Epub 2018 Feb 1.

10.

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.

Semmlinger A, von Schoenfeldt V, Wolf V, Meuter A, Kolben TM, Kolben T, Zeder-Goess C, Weis F, Gallwas J, Wuerstlein R, Hermelink K, Schmoeckel E, Harbeck N, Mayr D, Mahner S, Jeschke U, Ditsch N.

BMC Cancer. 2018 Apr 16;18(1):431. doi: 10.1186/s12885-018-4286-9.

11.

Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology.

Kolben T, Haberland B, Degenhardt T, Burgmann M, Koenig A, Kolben TM, Ulbach K, Mahner S, Bausewein C, Harbeck N, Wuerstlein R.

Arch Gynecol Obstet. 2018 Mar;297(3):767-773. doi: 10.1007/s00404-018-4681-0. Epub 2018 Jan 23.

PMID:
29362923
12.

Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling.

Kolben T, Jeschke U, Reimer T, Karsten N, Schmoeckel E, Semmlinger A, Mahner S, Harbeck N, Kolben TM.

J Cancer Res Clin Oncol. 2018 Feb;144(2):249-256. doi: 10.1007/s00432-017-2551-y. Epub 2017 Nov 28.

PMID:
29185091
13.

Short interval between two Pap smears: effect on the result of the second smear? A prospective randomized trial.

Kolben TM, Bergauer F, Moeckel J, Boettcher B, Thaler CJ, Kolben T, Crispin A, Dannecker C, Mahner S, Gallwas J.

Arch Gynecol Obstet. 2017 Jun;295(6):1427-1433. doi: 10.1007/s00404-017-4369-x. Epub 2017 Apr 12.

PMID:
28405743
14.

Local Resection of Primary Tumor in Upfront Stage IV Breast Cancer.

Kolben T, Kolben TM, Himsl I, Degenhardt T, Engel J, Wuerstlein R, Mahner S, Harbeck N, Kahlert S.

Breast Care (Basel). 2016 Dec;11(6):411-417. doi: 10.1159/000453573. Epub 2016 Dec 14.

15.

Detection of cervical intraepithelial neoplasia by using optical coherence tomography in combination with microscopy.

Gallwas J, Jalilova A, Ladurner R, Kolben TM, Kolben T, Ditsch N, Homann C, Lankenau E, Dannecker C.

J Biomed Opt. 2017 Jan 1;22(1):16013. doi: 10.1117/1.JBO.22.1.016013.

PMID:
28118427
16.

Structured Reporting of Rectal Magnetic Resonance Imaging in Suspected Primary Rectal Cancer: Potential Benefits for Surgical Planning and Interdisciplinary Communication.

Nörenberg D, Sommer WH, Thasler W, DʼHaese J, Rentsch M, Kolben T, Schreyer A, Rist C, Reiser M, Armbruster M.

Invest Radiol. 2017 Apr;52(4):232-239. doi: 10.1097/RLI.0000000000000336.

PMID:
27861230
17.

Expression of Sialyl Lewis a, Sialyl Lewis x, Lewis y, Gal-3, Gal-7, STMN1 and p16 in cervical dysplasia.

Kolben TM, Kraft F, Kolben T, Goess C, Semmlinger A, Dannecker C, Schmoeckel E, Mayr D, Sommer NN, Mahner S, Jeschke U.

Future Oncol. 2017 Jan;13(2):145-157. Epub 2016 Sep 20.

PMID:
27646625
18.

Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes.

Kolben T, Hary T, Holdt LM, Schwarz TM, Goess C, Wuerstlein R, Gallwas J, Toth B, Weissenbacher T, Jeschke U, Harbeck N, Ditsch N.

Anticancer Res. 2016 Jun;36(6):3185-90.

PMID:
27272846
19.

HPV vaccination: acceptance and influencing factors among young men in Germany.

Schwarz TM, Honsberg T, Stephan N, Dannecker C, Gallwas J, Crispin A, Weißenbacher ER, Kolben T.

Future Microbiol. 2016;11(2):227-34. doi: 10.2217/fmb.15.132. Epub 2015 Dec 16.

PMID:
26673226
20.

Impact of guideline-based use of uPA/PAI-1 on patient outcome in intermediate-risk early breast cancer.

Kolben T, Augustin D, Armbrust R, Kolben TM, Degenhardt T, Burgmann M, Goess C, Ditsch N, Kates R, Harbeck N, Wuerstlein R.

Breast Cancer Res Treat. 2016 Jan;155(1):109-15. doi: 10.1007/s10549-015-3653-3. Epub 2015 Dec 7.

PMID:
26643086

Supplemental Content

Loading ...
Support Center